Zacks Investment Research
30 Oct 2026, 15:51 UTC · 1h ago
STERIS Set to Report Q2 Earnings: What's in the Cards for the Stock?
Impact · against what's priced in
The upcoming Q2 earnings report for STERIS acts as a binary event to confirm if the company can hit consensus targets. While acquisitions provide a small tailwind, the primary catalyst will be whether EPS reaches the $2.67 target.
- STE+0.10
No priced-in read yet
- In context
The market is awaiting November 4 results to see if STERIS meets a consensus EPS of $2.67 and revenue of $1.56 billion, representing year-over-year growth of 8.1% and 7.1% respectively.
Read from the article alone
Top 1 mover · tap to explore
